Proteome analysis of cultivated vascular smooth muscle cells from a CADASIL patient

Molecular Medicine

Volumn 13, Issue 5-6, 2007, Pages 305-314

  Ihalainen, Saara ^a,b   Soliymani, Rabah ^a   Iivanainen, Erika ^c   Mykkänen, Kati ^c   Sainio, Annele ^c   Pöyhönen, Minna ^b   Elenius, Klaus ^c,d,e   Järveläinen, Hannu ^c,e   Viitanen, Matti ^c,f   Kalimo, Hannu ^b,c,g   Baumann, Marc ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYSTEINE; EPIDERMAL GROWTH FACTOR; NOTCH3 RECEPTOR; PROTEOME; REACTIVE OXYGEN METABOLITE;

AMINO ACID SEQUENCE; ARTICLE; CADASIL; CELL CULTURE; CELL PROLIFERATION; CELL STRESS; CELL SURFACE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MISSENSE MUTATION; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE;

CADASIL; CELLS, CULTURED; COLLAGEN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GELS; GENE EXPRESSION PROFILING; HUMANS; INFANT, NEWBORN; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEINS; PROTEOME;

EID: 34547409798     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2006-00069.Ihalainen     Document Type: Article

References (77)

1. Joutel A et al. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105:597-605.
2. Joutel A et al. (1997) Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 350:1511-5.
3. Dichgans M, Ludwig H, Muller-Hocker J, Messerschmidt A, Gasser T. (2000) Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur. J. Hum. Genet. 8:280-5.
4. Brou C et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol. Cell. 5:207-16.
5. Mumm JS et al. (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol. Cell. 5:197-206.
6. De Strooper B et al. (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 398:518-22.
7. Artavanis-Tsakonas S, Rand MD, Lake RJ. (1999) Notch signaling: cell fate control and signal integration in development. Science 284:770-6.
8. Karlstrom H, Beatus P, Dannaeus K, Chapman G, Lendahl U, Lundkvist J. (2002) A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc. Natl. Acad. Sci. U. S. A. 99:17119-24.
9. Peters N, Opherk C, Zacherle S, Capell A, Gempel P, Dichgans M. (2004) CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp. Cell Res. 299:454-64.
10. Joutel A, Monet M, Domenga V, Riant F, Tournier-Lasserve E. (2004) Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling pathway. Am. J. Hum. Genet. 74:338-47.
11. Mykkanen K et al. (2004) Detection of the founder effect in Finnish CADASIL families. Eur. J. Hum. Genet. 12:813-9.
12. Gimbrone MA,Jr, Cotran RS, Folkman J. (1974) Human vascular endothelial cells in culture: growth and DNA synthesis. J. Cell Biol. 60:673-84.
13. Gimbrone MA Jr, Cotran RS. (1975) Human vascular smooth muscle in culture. Growth and ultrastructure. Lab. Invest. 33:16-27.
14. Nandi D, Tahiliani P, Kumar A, Chandu D. (2006) The ubiquitin-proteasome system. J. Biosci. 31:137-55.
15. Sayeed A, Ng DT. (2005) Search and destroy: ER quality control and ER-associated protein degradation. Crit. Rev. Biochem. Mol. Biol. 40:75-91.
16. Zhang K, Kaufman RJ. (2006) The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66 Suppl:S102-9.
17. Liu J, Chen Q, Huang W, Horak KM, Zheng H, Mestril R, Wang X. (2006) Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 20:362-4.
18. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. (2004) Molecular pathways to neurodegeneration. Nat. Med. 10 Suppl:S2-9.
19. Wilkinson KD. (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1245-56.
20. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell. 111:209-18.
21. Haglund K, Di Fiore PP, Dikic I. (2003) Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem. Sci. 28:598-603.
22. Levkowitz G et al. (1998) c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:3663-74.
23. Outeiro TF et al. (2006) Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem. Biophys. Res. Commun. 351:631-8.
24. Lee S, Carson K, Rice-Ficht A, Good T. (2006) Small heat shock proteins differentially affect Abeta aggregation and toxicity. Biochem. Biophys. Res. Commun. 347:527-33.
25. Ishiko A, Shimizu A, Nagata E, Takahashi K, Tabira T, Suzuki N. (2006) Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol. (Berl). 112:333-9.
26. Roine S et al. (2006) Ophthalmologic findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a cross-sectional study. Ophthalmology. 113:1411-7.
27. Harju M et al. (2004) Scanning laser Doppler flowmetry shows reduced retinal capillary blood flow in CADASIL. Stroke 35:2449-52.
28. Singhal S, Markus HS. (2005) Cerebrovascular reactivity and dynamic autoregulation in nondemented patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). J. Neurol. 252:163-7.
29. Chabriat H et al. (2000) Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke 31:1904-12.
30. Pfefferkorn T, von Stuckrad-Barre S, Herzog J, Gasser T, Hamann GF, Dichgans M. (2001) Reduced cerebrovascular CO(2) reactivity in CADASIL: a transcranial Doppler sonography study. Stroke 32:17-21.
31. Hussain MB, Singhal S, Markus HS, Singer DR. (2004) Abnormal vasoconstrictor responses to angiotensin II and noradrenaline in isolated small arteries from patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 35:853-8.
32. Grizot S, Faure J, Fieschi F, Vignais PV, Dagher MC, Pebay-Peyroula E. (2001) Crystal structure of the Rac1-RhoGDI complex involved in NADPH oxidase activation. Biochemistry 40:10007-13.
33. Ueda T, Kikuchi A, Ohga N, Yamamoto J, Takai Y. (1990) Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein. J. Biol. Chem. 265:9373-80.
34. Ando S et al. (1992) Post-translational processing of rac p21s is important both for their interaction with the GDP/GTP exchange proteins and for their activation of NADPH oxidase. J. Biol. Chem. 267:25709-13.
35. Leonard D, Hart MJ, Platko JV, Eva A, Henzel W, Evans T, Cerione RA. (1992) The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J. Biol. Chem. 267:22860-8.
36. Michaelson D, Silletti J, Murphy G, D'Eustachio P, Rush M, Philips MR. (2001) Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152:111-26.
37. Lee DL, Webb RC, Jin L. (2004) Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension 44:796-9.
38. Moriki N et al. (2004) RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Hypertens. Res. 27:263-70.
39. Matsui T et al. (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15:2208-16.
40. Kimura K et al. (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-8.
41. Fukata Y, Amano M, Kaibuchi K. (2001) Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci. 22:32-9.
42. Kaneko T, Amano M, Maeda A, Goto H, Takahashi K, Ito M, Kaibuchi K. (2000) Identification of calponin as a novel substrate of Rho-kinase. Biochem. Biophys. Res. Commun. 273:110-6.
43. Meier M, King GL, Clermont A, Perez A, Hayashi M, Feener EP. (2001) Angiotensin AT(1) receptor stimulates heat shock protein 27 phosphorylation in vitro and in vivo. Hypertension 38:1260-5.
44. Somara S, Bitar KN. (2004) Tropomyosin interacts with phosphorylated HSP27 in agonist-induced contraction of smooth muscle. Am. J. Physiol. Cell. Physiol. 286:0290-301.
45. Patil SB, Tsunoda Y, Pawar MD, Bitar KN. (2004) Translocation and association of ROCK-II with RhoA and HSP27 during contraction of rabbit colon smooth muscle cells. Biochem. Biophys. Res. Commun. 319:95-102.
46. Wang P, Bitar KN. (1998) Rho A regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27. Am. J. Physiol. 275:G1454-62.
47. Gutsche-Perelroizen I, Lepault J, Ott A, Carlier MF. (1999) Filament assembly from profilin-actin. J. Biol. Chem. 274:6234-43.
48. Tang DD, Tan J. (2003) Downregulation of profilin with antisense oligodeoxynucleotides inhibits force development during stimulation of smooth muscle. Am. J. Physiol. Heart Circ. Physiol. 285:H1528-36.
49. Yang C et al. (2000) Profilin enhances Cdc42-induced nucleation of actin polymerization. J. Cell Biol. 150:1001-12.
50. Carlier MF, Pantaloni D. (1997) Control of actin dynamics in cell motility. J. Mol. Biol. 269:459-67.
51. Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S. (1999) Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat. Cell Biol. 1:136-43.
52. Higgs HN, Pollard TD. (2000) Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. J. Cell Biol. 150:1311-20.
53. Witke W, Podtelejnikov AV, Di Nardo A, Sutherland JD, Gurniak CB, Dotti C, Mann M. (1998) In mouse brain profilin I and profilin II associate with regulators of the endocytic pathway and actin assembly. EMBO J. 17:967-76.
54. Harper BD, Beckerle MC, Pomies P. (2000) Fine mapping of the alpha-actinin binding site within cysteine-rich protein. Biochem. J. 350 Pt 1:269-74.
55. Louis HA, Pino JD, Schmeichel KL, Pomies P, Beckerle MC. (1997) Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J. Biol. Chem. 272:27484-91.
56. Henderson JR, Macalma T, Brown D, Richardson JA, Olson EN, Beckerle MC. (1999) The LIM protein, CRP1, is a smooth muscle marker. Dev. Dyn. 214:229-38.
57. Warner BB, Stuart L, Gebb S, Wispe JR. (1996) Redox regulation of manganese superoxide dismutase. Am. J. Physiol. 271:L150-8.
58. Melov S. (2002) Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann. N. Y. Acad. Sci. 959:330-40.
59. Hayes JD, Flanagan JU, Jowsey IR. (2005) Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45:51-88.
60. Friedlander R, Jarosch E, Urban J, Volkwein C, Sommer T. (2000) A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat. Cell Biol. 2:379-84.
61. Tu BP, Weissman JS. (2004) Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164:341-6.
62. Haynes CM, Titus EA, Cooper AA. (2004) Degradation of misfolded proteins prevents ER-derived oxidative stress and cell death. Mol. Cell. 15:767-76.
63. Cuozzo JW, Kaiser CA. (1999) Competition between glutathione and protein thiols for disulphide-bond formation. Nat. Cell Biol. 1:130-5.
64. Kohno T et al. (1996) Relation of oxidative stress and glutathione synthesis to CD95(Fas/APO-1)-mediated apoptosis of adult T cell leukemia cells. J. Immunol. 156:4722-8.
65. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J. 13:2061-70.
66. Merad-Boudia M, Nicole A, Santiard-Baron D, Saille C, Ceballos-Picot I. (1998) Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56:645-55.
67. Annunen-Rasila J et al. (2006) Mitochondrial DNA sequence variation and mutation rate in patients with CADASIL. Neurogenetics 7:185-94.
68. Fabry B, Maksym GN, Shore SA, Moore PE, Panettieri RA Jr, Butler JP, Fredberg JJ. (2001) Selected contribution: time course and heterogeneity of contractile responses in cultured human airway smooth muscle cells. J. Appl. Physiol. 91:986-94.
69. Tolic-Norrelykke IM, Wang N. (2005) Traction in smooth muscle cells varies with cell spreading. J. Biomech. 38:1405-12.
70. Tuominen S et al. (2004) Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients. Stroke 35:1063-7.
71. Rufa A, Dotti MT, Frezzotti P, De Stefano N, Caporossi A, Federico A. (2004) Hemodynamic evaluation of the optic nerve head in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Arch. Neurol. 61:1230-3.
72. Yamakawa T, Tanaka S, Numaguchi K, Yamakawa Y, Motley ED, Ichihara S, Inagami T. (2000) Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells. Hypertension 35:313-8.
73. Gohla A, Schultz G, Offermanns S. (2000) Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ. Res. 87:221-7.
74. Wassmann S et al. (2001) Inhibition of geranyl-geranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol. Pharmacol. 59:646-54.
75. Slice LW, Chiu T, Rozengurt E. (2005) Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J. Biol. Chem. 280:1582-93.
76. Campos AH, Wang W, Pollman MJ, Gibbons GH. (2002) Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ. Res. 91:999-1006.
77. Ford CM, Li S, Pickering JG. (1999) Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler. Thromb. Vasc. Biol. 19:1843-51.